Abstract
Patients with acute leukemia present with a prolonged and severe course of COVID-19, which is paralleled by high rates of viremia.
Low-intensive chemotherapy seems to be more feasible in patients with acute myeloid leukemia and concomitant SARS-CoV-2 infection.
MeSH terms
-
Adult
-
Aged
-
Antimetabolites, Antineoplastic / therapeutic use*
-
Azacitidine / therapeutic use
-
COVID-19 / complications
-
COVID-19 / diagnosis*
-
COVID-19 / virology
-
Cytarabine / therapeutic use*
-
Extracorporeal Membrane Oxygenation
-
Female
-
Humans
-
Leukemia, B-Cell / complications
-
Leukemia, B-Cell / drug therapy
-
Leukemia, Myeloid, Acute / complications
-
Leukemia, Myeloid, Acute / drug therapy*
-
Male
-
Middle Aged
-
RNA, Viral / metabolism
-
Reverse Transcriptase Polymerase Chain Reaction
-
SARS-CoV-2 / genetics
-
SARS-CoV-2 / isolation & purification
-
Treatment Outcome
Substances
-
Antimetabolites, Antineoplastic
-
RNA, Viral
-
Cytarabine
-
Azacitidine